Morning Overview on MSN
Brain scans on psychedelics reveal how wild visual hallucinations form
A growing body of neuroimaging research is pinpointing exactly how psychedelic drugs hijack the brain’s visual system to ...
A new psychedelic retreat calling itself a “SETI for the mind” aims to establish two-way communication with the nonhuman entities people encounter while tripping on DMT.
The modern journey began when Swiss chemist Albert Hofmann synthesised LSD in 1938. In the 1970s and 80s, researchers found that these drugs attach to a specific brain receptor (called 5-HT2A) that ...
Medical Device Network on MSN
Cognito Therapeutics raises $105m for Alzheimer’s therapeutic advancement
With a pivotal trial readout for Cognito’s Spectris due later this year, the company anticipates launching the Alzheimer’s ...
Tripping on psychedelics is hard to describe to someone who’s never been through the experience. Every psychedelic trip is ...
Completed enrollment in 4D-150 4FRONT-1 wet AMD Phase 3 trial within approximately 11 months, ahead of initial projections and reflecting strong interest from investigators and patients; topline data ...
Baidu’s Apollo Go, WeRide and Pony.ai have been granted permits by Dubai’s Roads and Transport Authority (RTA) to conduct autonomous driving trials on the emirate’s roads, enabling the companies to ...
A psychoactive ingredient found in ayahuasca, a brew used in shamanistic rituals in South America, has shown promise as a treatment for depression in a phase 2a trial. In the study, 34 people living ...
"The general level of hypervigilance is rising across society," says curator Mark Atkin. "Embedded within each experience is a form of resistance or rebellion." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results